Effect of an oral supplementation with a formula containing R-lipoic acid in glaucoma patients

2020

Abstract Objective To analyse the safety and effectiveness of the oral administration of a commercialised supplement containing R-alpha lipoic acid (ALA), taurine, vitamins C and E, lutein, zeaxanthin, zinc, copper and docosahexaenoic acid (DHA), in patients with primary open angle glaucoma (POAG), and in control subjects. Material and methods A prospective study of cases and controls was carried out, including 30 participants of both genders that were divided into: POAG Group (n = 15) and a control group (CG; n = 15), assigned to the oral intake of NuaDHA preparations Vision® (1 pill/day) + NuaDHA 1000 (2 pills/day) for 6 months. Participants were interviewed, ophthalmologically examined, …

New horizons for the treatment of glaucoma. I: Neuroinflammation and inflammasomes

2018

Efficacy and safety study of an eyelid gel after repeated nocturnal application in healthy contact lens users and non-users

2020

Purpose: To evaluate skin biocompatibility of a nighttime hydrating eyelid gel and possible ocular surface effects in contact lens users (CLU) and non-contact lens users (NCLU). The formulation is registered as a medical device as Tridocosahexaenoine-AOX® (TDHA-AOX) (a concentrated DHA triglyceride), containing also hyaluronic acid (HA). Methods: A prospective, randomized, masked clinical trial was performed with 62 participants of both sexes, aged 20–70 years, split into: (1) CLU (n = 30) and (2) NCLU (n = 32). All participants were instructed to apply a single dose of the moisturizing gel (containing TDHA-AOX and HA) nightly to the upper and inner eyelids of their right eye (RE) only, and…

miRNAs and Genes Involved in the Interplay between Ocular Hypertension and Primary Open-Angle Glaucoma. Oxidative Stress, Inflammation, and Apoptosis…

2021

Este artículo se encuentra disponible en la siguiente URL: https://www.mdpi.com/2077-0383/10/11/2227 En esta investigación también participan: Mar Valero Vello, Silvia M. Sanz González, José E. O'Connor, David Galarreta Mira, María D. Pinazo-Durán y Vicente Zanón Moreno. Este artículo pertenece al número especial "Recent Clinical Research on Glaucoma". Glaucoma has no cure and is a sight-threatening neurodegenerative disease affecting more than 100 million people worldwide, with primary open angle glaucoma (POAG) being the most globally prevalent glaucoma clinical type. Regulation of gene expression and gene networks, and its multifactorial pathways involved in glaucoma disease are landmark…

Identificación de nuevos genes candidatos para la retinopatía en diabéticos tipo 2. Estudio Valencia sobre Retinopatía Diabética (EVRD). Informe n.° 3

2018

Resumen Objetivo Identificar genes implicados en los mecanismos patogenicos de la retinopatia diabetica no proliferante, como estres oxidativo, alteracion de la matriz extracelular y/o apoptosis, para valorar el riesgo de desarrollo de la misma en una poblacion de diabeticos tipo 2 (DM2). Material y metodos Estudio de casos y controles en 81 participantes del Estudio Valencia sobre Retinopatia Diabetica (EVRD), de ambos sexos y con edades comprendidas entre los 25 y 85 anos, clasificados en: 1) grupo DM2 (n = 49), con RD (+RD; n = 14) y sin RD (−RD; n = 35), y 2) grupo control (GC; n = 32). Se realizo entrevista personal, examen oftalmologico estandarizado y extraccion de sangre que se proc…

Identification of new candidate genes for retinopathy in type 2 diabetics. Valencia Study on Diabetic Retinopathy (VSDR). Report number 3

2018

Abstract Objective To identify genes involved in the pathogenic mechanisms of non-proliferative diabetic retinopathy (NPDR), among which include oxidative stress, extracellular matrix changes, and/or apoptosis, in order to evaluate the risk of developing this retinal disease in a type 2 diabetic (DM2) population. Material and methods A case–control study was carried out on 81 participants from the Valencia Study on Diabetic Retinopathy (VSDR) of both genders, with ages 25–85 years. They were classified into: (i) DM2 group (n = 49), with DR (+DR; n = 14) and without DR (−DR; n = 35), and (ii) control group (GC; n = 32). The protocols included a personal interview, standardized ophthalmologic…

Efecto de la suplementación oral con una fórmula que contiene ácido R-lipoico en pacientes con glaucoma

2020

Resumen Objetivo Analizar la seguridad y efectividad de la administracion oral de un suplemento comercializado que contiene acido alfa-R-lipoico, taurina, vitaminas C y E, luteina, zeaxantina, zinc, cobre y acido docosahexaenoico en pacientes con glaucoma primario de angulo abierto (GPAA) y sujetos control. Material y metodos Se realizo un estudio prospectivo de casos y controles que incluyo 30 participantes de ambos sexos, divididos en: pacientes con GPAA (n = 15) y sujetos sanos (GC; n = 15) asignados a tomar durante 6 meses los preparados NuaDHA Vision® (1 comp/dia) + NuaDHA 1000 (2 comps/dia). Los participantes fueron entrevistados, examinados oftalmologicamente, extrayendo sangre perif…